RightSign® Oncology Tests have been developed with selected reagents from industry-leading sophisticated suppliers to deliver accurate results every time an individual makes the sophisticated choice of using RightSign® Oncology Tests. These tests offer a reliable and convenient solution for detecting a wide range of drugs of abuse, ensuring peace of mind with their precision and ease of use.

 

Our RightSign®Oncology Rapid Tests include Whole Blood,Serum,Feces and Plasma test kits, designed for both professional and at-home use. The tests are capable of detecting 8 common types abused substances, including AFP (alpha-fetoprotein) Rapid Tests, CEA (carcinoembryonic antigen) Rapid Tests and FOB (feces occult blood) Rapid Tests , among others. Each test provides results in as little as 5 minutes, offering high sensitivity and specificity with minimal risk of false positives or negatives.

 

 
 
The Oncology Tests Manufacturer!
 

Hangzhou Biotest Biotech Co., Ltd. supplies major IVD categories: Fertility health, drug testing/toxicology, infectious disease identification, tumor marker detection and cardiac marker monitoring. Biotest harnesses the world-leading technologies of bioengineering by using gene recombinant antigens, synthetic antigens, mono-specific antibodies and polyclonal antibodies combined with latex and colloidal metal particles on immuno-chromatographic assay scaffold to accomplish our test development goals.

 

Why choose us
 

Our Patent Certification
As of December 2023, the company has 230 patented technologies, including 171 domestic patents (9 invention patents) and 59 overseas patents (7 Invention patents). Obtained 45 NMPA certificates, EU CE certificates covering 603 products, and 3 US FDA 510(k) certificates covering 21 test products. Products are sold to more than 100 countries and regions around the world.

 

Global Market
In 2015, Hangzhou Biotest Biotech Co., Ltd completed the acquisition of Advin Biotechnology Co., Ltd. of the United States. With the technology and talent advantages of the Silicon Valley of the United States, and adhering to the strategy of global research and development, Biotest not only established to provide innovative, timely, high-quality products for the global market, but also offering solution program and development center.

 

Professional Team
Biotest is one of the manufacturers with a relatively complete variety of POCT diagnostic reagents in the world. Relying on strong independent innovation and management capabilities, Biotest has established a rapid immunodiagnosis platform, a POCT application technology platform, a biological core raw material technology platform, an automated production technology platform and other industrial technology platforms.

 

Parameters

Acceptance Criteria

Physical Appearance

Clear Protein Solution

CA 125 Concentration (CLIA Method)

≥ 70,000 IU/ml

Purity

Specific Protein to total protein should be ≥ 10,000 IU/ml/OD

Cross Contaminants

CA 15-3, CA 19-9 concentrations should be ≤ 20% of CA 125 concentration

CEA, AFP and Transferrin Content

As per customer requirement

Form

Liquid

Storage buffer

Tris Saline with 15mM NaN3, pH 7.4 ± 0.2

Storage temperature

2 to 8˚C

Shelf life

3 years

Anti HIV1&2 (ELISA)

Negative

Anti HCV (ELISA)

Negative

HBsAg Antigen (ELISA)

Negative

HBV DNA (PCR)

Not Detected

HCV RNA (PCR)

Not Detected

HIV DNA (PCR)

Not Detected

Source of the product

Human ascitic fluid

 

Advantages of Cancer Antigen Rapid Test Cassette
 
FOB Test Cassette

Speedy Results: Rapid antigen tests provide results in a matter of minutes, enabling prompt identification of infected individuals. This rapid turnaround time is invaluable in swiftly isolating cases and preventing further transmission within communities.


Ease of Use: Unlike some other diagnostic methods, rapid antigen tests are simple to administer and do not require specialised equipment or trained medical professionals. They can be conducted in various settings, from healthcare facilities to workplaces and even at home, facilitating widespread testing efforts.


Early Detection: Early detection is key to controlling outbreaks. Rapid antigen tests are effective in detecting the virus during the early stages of infection, even before symptoms appear. This early identification allows for timely intervention, reducing the risk of widespread transmission.

Cost-Effectiveness: Rapid antigen test kits are generally more affordable compared to other diagnostic methods, making them accessible to a broader segment of the population. Their affordability promotes regular testing, especially in high-risk environments, contributing to proactive disease management.


Screening Tool: Rapid antigen tests serve as valuable screening tools for large scale testing initiatives, such as screening travellers at airports or screening employees before entering workplaces. By quickly identifying asymptomatic carriers, these tests help prevent outbreaks in vulnerable settings.


Complementary to PCR Testing: While polymerase chain reaction (PCR) tests remain the gold standard for diagnosing infectious diseases, rapid antigen tests complement PCR testing efforts. They can be used for initial screening or to confirm suspected cases, conserving PCR resources for confirmatory testing when needed.

Psa Rapid Test

 

Convinient Procedure

 

Allow test cassette, specimen, and/or controls to equilibrate to room temperature (15-30°C) prior to testing.


Bring the pouch to room temperature before opening it. Remove the test cassette from the sealed pouch and use it as soon as possible. Best results will be obtained if the assay is performed within one hour.


Place the cassette on a clean and level surface. For Serum, Plasma or Venipuncture Whole Blood specimen:
• Hold the dropper vertically and transfer 1 drop of serum or plasma (approximately 40µl) or 2 drops of venipuncture whole blood (approximately 80 µl)) to the specimen well (S) of thecassette, then add 1 drop of buffer (approximately 40µl) and start the timer.See illustration below.


For Fingerstick Whole Blood specimen:
• To use a capillary tube: Fill the capillary tube and transfer approximately 80 µl of fingerstick whole blood specimen to the specimen area of test cassette, then add 1 drop of buffer (approximately 40µl) and start the timer. See illustration below.


Wait for the colored line(s) to appear .Read results at 10 minutes. Do not interrupt the result after 20minutes.

 

 

Packaging & Shipping

 

productcate-852-655

 

FAQ

 

Q: Can cancer antigens detect all cancers?

A: No, cancer antigens cannot detect all cancers. Some cancers do not produce specific antigens, while others may produce antigens only at later stages.

Q: How accurate are cancer antigen tests?

A: Cancer antigen tests are useful but not definitive, as they can sometimes lead to false positives or negatives. They are often combined with other diagnostic tools.

Q: Is PSA a reliable test for prostate cancer?

A: PSA testing is valuable but not foolproof. High levels may indicate prostate issues, but not always cancer, which is why additional testing is essential.

Q: What is the future of cancer antigen research?

A: Cancer antigen research is evolving towards precision medicine, with a focus on creating personalized treatments based on genetic profiles.

Q: How are cancer antigens used in immunotherapy?

A: In immunotherapy, cancer antigens help identify and target cancer cells, improving the immune system's ability to destroy them through techniques like CAR T-cell therapy.

We're professional oncology tests manufacturers and suppliers in China, specialized in providing high quality custom service. We warmly welcome you to wholesale cheap oncology tests from our factory.

Psa Rapid Test, Cea Rapid Test, Lactoferrin Rapid Test